These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 20538515)

  • 41. Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany.
    Wiese-Posselt M; Siedler A; Mankertz A; Sauerbrei A; Hengel H; Wichmann O; Poethko-Müller C
    BMC Infect Dis; 2017 May; 17(1):356. PubMed ID: 28525973
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Maternal varicella history as a predictor of varicella immune status.
    Silverman NS; Ewing SH; Todi N; Montgomery OC
    J Perinatol; 1996; 16(1):35-8. PubMed ID: 8869538
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Seroepidemiology of varicella-zoster virus infection measured by the fluorescent antibody to membrane antigen test].
    Liu JJ; Wang ML; Gan L; Liao WJ; Chen J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Apr; 30(4):371-5. PubMed ID: 19731531
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Investigation on sera prevalence rate of varicella and immunogenicity of varicella vaccine in healthy children].
    Zhou T; Wang J; Qiu P
    Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Oct; 19(5):271-3. PubMed ID: 10322684
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nosocomial transmission of chickenpox and varicella zoster virus seroprevalence rate amongst healthcare workers in a teaching hospital in China.
    Yang J; Liu J; Xing F; Ye H; Dai G; Liu M; Lo SK; Lau RW; Chiu KH; Chan JF; Yuen KY
    BMC Infect Dis; 2019 Jul; 19(1):582. PubMed ID: 31277589
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Age related seroprevalence of antibodies to varicella in India.
    Lokeshwar MR; Agrawal A; Subbarao SD; Chakraborty MS; Ram Prasad AV; Weil J; Bock HL; Kanwal S; Shah RC; Shah N
    Indian Pediatr; 2000 Jul; 37(7):714-9. PubMed ID: 10906803
    [TBL] [Abstract][Full Text] [Related]  

  • 47. THE changing seroepidemiology of varicella in Japan: 1977-1981 and 2001-2005.
    Ueno-Yamamoto K; Tanaka-Taya K; Satoh H; Araki K; Kaku M; Okabe N
    Pediatr Infect Dis J; 2010 Jul; 29(7):667-9. PubMed ID: 20228693
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
    Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
    Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The prevalence of varicella-zoster virus infection in normal healthy individuals aged above 6 months.
    Kowitdamrong E; Pancharoen C; Thammaborvorn R; Bhattarakosol P
    J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S7-11. PubMed ID: 16622994
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus].
    Bonmarin I; Santa-Olalla P; Lévy-Bruhl D
    Rev Epidemiol Sante Publique; 2008 Oct; 56(5):323-31. PubMed ID: 18951741
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Varicella zoster virus infection occurs at a relatively young age in The Netherlands.
    van Lier A; Smits G; Mollema L; Waaijenborg S; Berbers G; van der Klis F; Boot H; Wallinga J; de Melker H
    Vaccine; 2013 Oct; 31(44):5127-33. PubMed ID: 23973248
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence of varicella-zoster virus infection in Singapore.
    Ooi PL; Goh KT; Doraisingham S; Ling AE
    Southeast Asian J Trop Med Public Health; 1992 Mar; 23(1):22-5. PubMed ID: 1523475
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Seroprevalence of antibodies against varicella-zoster virus among prevalent hemodialysis patients.
    Talebi-Taher M; Hassanzadeh T; Ossareh S
    Iran J Kidney Dis; 2013 Nov; 7(6):475-8. PubMed ID: 24241094
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Seroprevalence of varicella-zoster virus among pregnant women in Fayoum Governorate, Egypt.
    Ibrahim EG; Abdel Wahed WY; Eid HM; Deeb WS
    J Egypt Public Health Assoc; 2019; 94(1):2. PubMed ID: 30686830
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunogenicity of Oka/Merck varicella vaccine in children vaccinated at 12-14 months of age versus 15-23 months of age.
    Silber JL; Chan IS; Wang WW; Matthews H; Kuter BJ
    Pediatr Infect Dis J; 2007 Jul; 26(7):572-6. PubMed ID: 17596796
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy.
    Nagel MA; Forghani B; Mahalingam R; Wellish MC; Cohrs RJ; Russman AN; Katzan I; Lin R; Gardner CJ; Gilden DH
    Neurology; 2007 Mar; 68(13):1069-73. PubMed ID: 17287447
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Varicella vaccination in HIV-1-infected children after immune reconstitution.
    Bekker V; Westerlaken GH; Scherpbier H; Alders S; Zaaijer H; van Baarle D; Kuijpers T
    AIDS; 2006 Nov; 20(18):2321-9. PubMed ID: 17117018
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Persistence of immunity to live attenuated varicella vaccine in healthy adults.
    Ampofo K; Saiman L; LaRussa P; Steinberg S; Annunziato P; Gershon A
    Clin Infect Dis; 2002 Mar; 34(6):774-9. PubMed ID: 11830801
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epidemiologic lessons: chickenpox outbreak investigation in a rural community around Chandigarh, North India.
    Singh MP; Singh G; Kumar A; Singh A; Ratho RK
    Indian J Pathol Microbiol; 2011; 54(4):772-4. PubMed ID: 22234108
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictive value of a self-reported history of varicella infection in determining immunity in adults.
    Holmes CN; Iglar KT; McDowell BJ; Glazier RH
    CMAJ; 2004 Nov; 171(10):1195-6. PubMed ID: 15534312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.